Cleveland Clinic

Latest from Cleveland Clinic


Dr Roxana Siles: QOL Improves Greatly From Effective Chronic Cough Treatment

June 14, 2022

Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, address the impact of effective treatments of chronic cough on patient quality of life (QOL).

Dr Roxana Siles: We Need to Address the Needs of Patients With Refractory/Unexplained Cough

May 22, 2022

Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, discusses the important need for chronic cough therapies and what issues with current treatments should be addressed by next-generation medications.

How Do Education, Social Support Affect PAP Adherence in Patients With OSA?

May 07, 2021

The group-based Sleep Apnea Management clinic at Cleveland Clinic's Sleep Disorders Center increased criteria-met adherence to positive airway pressure (PAP) therapy by 20% in patients with obstructive sleep apnea (OSA).

The Role of SGLT-2 Inhibitors in Heart Failure: A Roundtable Discussion

September 18, 2020

The American Journal of Managed Care® recently hosted a Peer Exchange that featured discussion among a panel of expert cardiologists and managed care decision makers regarding how cardiovascular outcome trial results are impacting the use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in patients with heart failure and how these drugs are shaping heart failure outcomes for patients. Panelists were Nihar R. Desai, MD, MPH, assistant professor of medicine in the cardiovascular medicine section of the Yale School of Medicine and investigator in the Center for Outcomes Research and Evaluation in New Haven, Connecticut; Jaime Murillo, MD, national senior director of cardiology at UnitedHealthcare in Fort Lauderdale, Florida; and Steven Nissen, MD, chief academic officer of the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute at the Cleveland Clinic in Cleveland, Ohio. The moderator was Neil B. Minkoff, MD, chief medical officer of Coeus Consulting Group in Sudbury, Massachusetts.